Cargando…
Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity
Charcot-Marie-Tooth disease type 2A (CMT2A) is an autosomal dominant neuropathy caused by mutations in the mitofusin 2 gene (MFN2). More than 100 MFN2 gene mutations have been reported so far, with majority located within the GTPase domain encoding region. These domain-specific mutations present wid...
Autores principales: | Beręsewicz, Małgorzata, Charzewski, Łukasz, Krzyśko, Krystiana A., Kochański, Andrzej, Zabłocka, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237821/ https://www.ncbi.nlm.nih.gov/pubmed/30442897 http://dx.doi.org/10.1038/s41598-018-35133-9 |
Ejemplares similares
-
The Effect of a Novel c.820C>T (Arg274Trp) Mutation in the Mitofusin 2 Gene on Fibroblast Metabolism and Clinical Manifestation in a Patient
por: Beręsewicz, Małgorzata, et al.
Publicado: (2017) -
A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene
por: KOTRUCHOW, KATARZYNA, et al.
Publicado: (2013) -
Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2)
por: Engelfried, Kathrin, et al.
Publicado: (2006) -
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
por: Franco, Antonietta, et al.
Publicado: (2022) -
Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene
por: Vinci, Paolo, et al.
Publicado: (2011)